Assistance Publique-Hopitaux de Paris (AP-HP)

Paris 75571

3 studies enrolling now · 6 studies all time

What they study most

Arthritis, Psoriatic, Community-acquired Pneumonia, Diffuse Cutaneous Systemic Sclerosis, Diffuse Large B-cell Lymphoma (DLBCL), Generalized Lipodystrophy, Relapsed/Refractory Follicular Lymphoma, Relapsed/Refractory Marginal Zone Lymphoma (R/R MZL)

Studies at this site

• A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Adult Patients With Previously Untreated Diffuse Large B-cell Lymphoma — Recruiting now
• Efficacy and Safety of Mibavademab in Adult and Pediatric Patients With Generalized Lipodystrophy — Recruiting now
• A Trial to Find Out if Odronextamab Combined With Lenalidomide is Safe and Works Better Than Rituximab Combined With Lenalidomide in Adult Participants With Follicular Lymphoma and Marginal Zone Lymphoma — Recruiting now
• Safety and Efficacy of AON-D21 in Severe Community-Acquired Pneumonia. — Completed
• Efficacy, Safety, and Tolerability Study of Apremilast to Treat Early Oligoarticular Psoriatic Arthritis. — Completed
• Efficacy and Safety of IgPro10 in Adults With Systemic Sclerosis (SSc) — Withdrawn before enrolling